Could smarter bread help Kids' weight and health?

NCT ID NCT07786675

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This randomized crossover trial tests whether nutritionally improved bread and bakery products—with less saturated fat and sugar and more fiber—can positively affect body composition and metabolic health in children aged 6 to 12 with overweight or obesity. Participants will consume these reformulated products for a period, then switch to conventional products, allowing each child to serve as their own control. The study measures changes in weight, body fat, lean mass, blood markers, and gut microbiota, along with how acceptable the products are to children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nutritionally improved bread and bakery products with reduced saturated fat and free sugars and increased fiber, compared to conventional products
What this could lead to
If effective, these reformulated products could offer a practical, everyday dietary strategy to help manage weight and metabolic health in children with overweight or obesity.
What could go wrong
This is a small crossover trial, and results may not generalize. The intervention is just one part of the diet, so its impact on body composition and metabolic markers may be modest or not clinically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Oct 2021

Finished

Mar 2023

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 6 to 12 years. * Overweight or obesity defined according to Cole et al. criteria. * Willingness and commitment to consume the study bread and bakery products as part of the nutritional intervention. * Written informed consent provided by a parent or legal guardian. Exclusion Criteria: * Diagnosed disorders related to glucose metabolism (e.g., diabetes mellitus). * Celiac disease. * Gastrointestinal disorders, including inflammatory bowel disease. * Current medical or pharmacological treatment that may interfere with the study outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pediatric obesity are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation obesity disorder Pediatric Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Growth, Exercise, Nutrition and Development (GENUD) Research Group - University of Zaragoza

    Zaragoza, Zaragoza, 50009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.